MML Investors Services’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Sell
6,180
-2,564
-29% -$217K ﹤0.01% 2600
2026
Q1
$869K Sell
8,744
-3,190
-27% -$416K ﹤0.01% 1869
2025
Q4
$1.45M Buy
11,934
+419
+4% +$52.6K ﹤0.01% 1572
2025
Q3
$1.29M Buy
11,515
+2,917
+34% +$341K ﹤0.01% 1556
2025
Q2
$1.15M Buy
8,598
+1,792
+26% +$197K ﹤0.01% 1577
2025
Q1
$458K Buy
6,806
+563
+9% +$38.7K ﹤0.01% 2038
2024
Q4
$389K Buy
6,243
+2,120
+51% +$197K ﹤0.01% 2094
2024
Q3
$647K Buy
4,123
+2,407
+140% +$371K ﹤0.01% 1708
2024
Q2
$258K Buy
+1,716
New +$206K ﹤0.01% 2186

Other funds holding TMDX

MML Investors Services's TMDX Position: Q2 2026 in Review

MML Investors Services reduced its Transmedics (TMDX) stake by 29% in Q2 2026, selling an estimated $217K and leaving 6,180 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

MML Investors Services first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.45M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • MML Investors Services held 6,180 shares of Transmedics worth $410K as of Q2 2026.
  • MML Investors Services sold 2,564 Transmedics shares in Q2 2026, an estimated $217K.
  • Transmedics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2600 holding.
  • MML Investors Services first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
  • MML Investors Services's Transmedics position peaked at $1.45M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.